BioAdaptives (BioAdaptives) Price-to-Operating-Cash-Flow : (As of May. 01, 2024)

View and export this data going back to 2014. Start your Free Trial

What is BioAdaptives Price-to-Operating-Cash-Flow?

As of today (2024-05-01), BioAdaptives's share price is $0.0006. BioAdaptives's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Hence, BioAdaptives's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for BioAdaptives's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 9 years, BioAdaptives's highest Price-to-Operating-Cash-Flow Ratio was 500.00. The lowest was 0.35. And the median was 98.50.

BDPT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 10.81
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

BioAdaptives's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

During the past 9 years, BioAdaptives's highest 3-Year average Operating Cash Flow per Share Growth Rate was 40.70% per year. The lowest was -21.60% per year. And the median was 39.40% per year.

BioAdaptives Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BioAdaptives's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioAdaptives Price-to-Operating-Cash-Flow Chart

BioAdaptives Annual Data

Trend

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

BioAdaptives Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BioAdaptives's Price-to-Operating-Cash-Flow

For the Packaged Foods subindustry, BioAdaptives's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioAdaptives's Price-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioAdaptives's Price-to-Operating-Cash-Flow falls into.

BioAdaptives Price-to-Operating-Cash-Flow Calculation

BioAdaptives's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0006	/	0
	=

BioAdaptives's Share Price of today is $0.0006.
BioAdaptives's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BioAdaptives Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioAdaptives's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BioAdaptives (BioAdaptives) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioAdaptives Inc (OTCPK:BDPT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128

Website

https://www.shopbioadaptives.com

BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.

Executives

Richard Chiang	other: Previous Officer and Director	460 BRANNAN STREET SUITE 78064, SAN FRANCISCO CA 94107
Barry Epling	director	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Ferris Holding Inc.	10 percent owner	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Gerald Epling	director, officer: Pres, CEO, Secretary, CFO	2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128